Own stem cell transplants for blood cancer in Upper Egypt
Part of Blood & lymphatic clinical trials.
This study looks at how well treatment works for people with blood cancers who receive a stem cell transplant using their own stem cells. It helps doctors understand the experience and outcomes in Upper Egypt.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with a blood cancer (like lymphoma, myeloma, or leukemia)
- You are scheduled to receive a stem cell transplant using your own stem cells
- You are willing to be part of the study
- You have not had a transplant from a donor, and you do not have an uncontrolled infection or severe organ failure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special type of stem cell transplant that may help people with certain blood cancers or bone marrow diseases. The transplant uses donor stem cells that are specially selected to reduce the risk of complications. It might be an option for patients who need a transplant to treat their condition.
This Phase 2 study tests a strong (myeloablative) stem cell transplant using donor stem cells (allogeneic transplant) for certain blood and bone marrow cancers. The goal is to see how well this approach works and whether it can improve outcomes for people who need transplant-level treatment.
This study looks at using stem cells from a donor's bone marrow or blood to treat blood cancers like leukemia or lymphoma. It compares transplants from partially matched donors with fully matched donors to see how well they work.
This trial tests a stem cell transplant using milder chemotherapy (treosulfan and fludarabine) followed by a drug called cyclophosphamide to prevent graft-versus-host disease. It aims to make transplant safer for people with blood diseases who cannot handle standard high-dose chemotherapy.
This trial tests a transplant using stem cells from an unrelated donor who is not a perfect match for your tissue type. It may be an option for people with blood cancers who can't find a fully matched related donor and need a transplant quickly.
This trial tests whether a stem cell transplant from a fully matched sibling donor can help people with serious blood disorders like sickle cell disease or thalassemia. It aims to replace the faulty blood system with a healthy one from the donor.
Hear when a new Bone Marrow Transplant Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.